SOL.CN - SOL Global Investments Corp.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
1.7500
+0.0900 (+5.42%)
As of 10:53AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close1.6600
Open1.7400
Bid1.7100 x 0
Ask1.7500 x 0
Day's Range1.7400 - 1.7900
52 Week Range1.0200 - 5.0000
Volume21,200
Avg. Volume126,963
Market Cap85.486M
Beta (3Y Monthly)1.44
PE Ratio (TTM)0.65
EPS (TTM)2.6960
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group2 hours ago

    SOL Global to announce fiscal 2019 financial results and strategic corporate update post market close July 29, 2019

    TORONTO, July 19, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (CSE:SOL (OTCPK:SOLCF - News) ) (Frankfurt:9SB.F - News) expect to release results for the years ended March 31, 2019 as well as a comprehensive corporate update on July 29, 2019 after market close. SOL Global also expect to provide detail on the Company's NAV in the release to provide the market and analysts with clarity on the substantial delta between their intrinsic value versus today's stock price. The Company will host a conference call Wednesday, August 7th, 2019 to discuss the corporate update in-depth.

  • CNW Group2 days ago

    SOL Global Announces US$6.5 Million Investment in CannCure

    TORONTO, July 17, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (CSE:SOL (OTCPK:SOLCF - News) ) (Frankfurt:9SB.F - News) is pleased to announce a US$6.5 million capital infusion in its portfolio company CannCure Investments Inc. ("CannCure"), an investment that is intended to fuel the growth of its position throughout the cannabis markets of Florida, Michigan, and California.

  • SOL Global Announces $15 Million Investment into Heavenly Rx
    CNW Group7 days ago

    SOL Global Announces $15 Million Investment into Heavenly Rx

    TORONTO, July 12, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (CSE:SOL.CN - News) (OTCQB:SOLCF - News) (Frankfurt: 9SB) is pleased to announce that it has purchased 37,662,500 common shares ("Heavenly Shares") in the capital of Heavenly Rx Ltd. ("Heavenly Rx") at a price of $0.40 for an aggregate subscription amount of CAD$15,065,000.  The subscription is part of a larger private offering by Heavenly Rx of Heavenly Shares (the "Offering"). As a result of this subscription, SOL Global now holds 42.0% of the issued and outstanding Heavenly Shares and the other shareholders of Heavenly Rx collectively hold the remaining 58.0%. The Heavenly Shares are subject to an indefinite hold period under applicable Canadian securities laws.

  • SOL Global Completes $50 Million Debenture Financing and Announces Corporate Update
    CNW Group11 days ago

    SOL Global Completes $50 Million Debenture Financing and Announces Corporate Update

    The Company intends to use the net proceeds for working capital and general corporate purposes and to primarily finance the continued build-out of SOL Global's robust hemp and CBD strategy via Heavenly Rx Ltd. and the build-out and acquisition of additional assets in Florida, Michigan and California for its previously-announced, new cannabis multi-state operator. The funds are expected to help ensure the execution of the Company's long term vision, strategic acquisitions and its ongoing investment in top-tier talent and operations across both its hemp/CBD and THC operations. The Debenture bears an interest rate of 6.0% per annum and will mature two (2) years from the date of closing, unless such maturity date is otherwise shortened due to the occurrence of certain independent milestones as set out within the terms and conditions of the Debenture.

  • CNW Grouplast month

    SOL Global Investments Corp. Acquires Securities of Frankly Inc.

    TORONTO , June 6, 2019 /CNW/ - SOL Global Investments Corp. (" SOL Global " or the " Company ") (CSE:SOL) (Frankfurt:9SB) (OTCQB: SOLCF) announces that it has acquired an aggregate ...

  • SOL Global Portfolio Company Heavenly Rx Announces Key Leadership Appointments
    CNW Group2 months ago

    SOL Global Portfolio Company Heavenly Rx Announces Key Leadership Appointments

    TORONTO, June 3, 2019 /CNW/ - Heavenly Rx Ltd., the international hemp and CBD-focused portfolio company of SOL Global Investments Corp. ("SOL Global" or the "Company") (CSE:SOL.CN - News) (OTCQB:SOLCF - News) (Frankfurt: 9SB) is pleased to announce key leadership appointments today, including bringing on two distinguished business personalities as Chief Executive Office and Chief Operating Officer. It is with great pleasure that SOL Global today announces the appointment of Paul Norman, former President of North America for the $13B food giant Kellogg, to serve as Chief Executive Officer and Chairman of its portfolio company, Heavenly Rx Ltd. ("Heavenly Rx"), effective immediately.

  • CNW Group2 months ago

    IIROC Trade Resumption - SOL

    VANCOUVER , May 31, 2019 /CNW/ - Trading resumes in: Company: SOL Global Investments Corp. CSE Symbol: SOL (All Issues) Resumption (ET): 9:30 AM IIROC can make a decision to impose a temporary suspension ...

  • CNW Group2 months ago

    /R E P E A T -- SOL Global and Goldstream Minerals Announce Proposed Reverse Takeover By CannCure Investments/

    TORONTO, May 30, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global") (CSE:SOL.CN - News) (OTCQB:SOLCF - News) (Frankfurt: 9SB) and Goldstream Minerals Inc. (NEX:GSX-H.V - News) ("Goldstream" or the "Company") are pleased to announce that Goldstream and CannCure Investments Inc. ("CannCure"), a portfolio company of SOL Global, have entered into a letter of intent dated as of May 29, 2019 (the "LOI") outlining the proposed terms and conditions pursuant to which Goldstream and CannCure will effect a business combination that will result in a reverse takeover of Goldstream by the shareholders of CannCure (the "Proposed Transaction"). The entity resulting from the Proposed Transaction (the "Resulting Issuer") will continue to carry on the business of CannCure as a multi-state vertically integrated cannabis company (the "MSO").

  • CNW Group2 months ago

    SOL Global and Goldstream Minerals Announce Proposed Reverse Takeover By CannCure Investments

    TORONTO, May 30, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global") (CSE:SOL.CN - News) (OTCQB:SOLCF - News) (Frankfurt: 9SB) and Goldstream Minerals Inc. (NEX:GSX-H.V - News) ("Goldstream" or the "Company") are pleased to announce that Goldstream and CannCure Investments Inc. ("CannCure"), a portfolio company of SOL Global, have entered into a letter of intent dated as of May 29, 2019 (the "LOI") outlining the proposed terms and conditions pursuant to which Goldstream and CannCure will effect a business combination that will result in a reverse takeover of Goldstream by the shareholders of CannCure (the "Proposed Transaction"). The entity resulting from the Proposed Transaction (the "Resulting Issuer") will continue to carry on the business of CannCure as a multi-state vertically integrated cannabis company (the "MSO").

  • CNW Group2 months ago

    IIROC Trading Halt - SOL

    VANCOUVER , May 30, 2019 /CNW/ - The following issues have been halted by IIROC: Company: SOL Global Investments Corp. CSE Symbol: SOL (all issues) Reason: At the request of the Company Pending News Halt ...

  • Market Exclusive2 months ago

    SOL Portfolio Company Acquires 50% Stake in Blühen Botanicals

    SOL Global Investments (CSE: SOL) (OTCQB: SOLCF) (Frankfurt: 9SB) announced that its portfolio company Heavenly Rx. Ltd. closed its US$30.06 million investment in Blühen Botanicals LLC, a hemp and hemp-derived CBD biomass farming, processing, extraction and retail company headquartered in Knoxville, Tenn. Heavenly Rx acquired a 50.1% stake in Blühen in exchange for $12.06 million […]The post SOL Portfolio Company Acquires 50% Stake in Blühen Botanicals appeared first on Market Exclusive.

  • SOL Global Portfolio Company Heavenly Rx Closes on Its $30.06 Million Investment in Blühen Botanicals
    CNW Group2 months ago

    SOL Global Portfolio Company Heavenly Rx Closes on Its $30.06 Million Investment in Blühen Botanicals

    TORONTO, May 23, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (CSE:SOL.CN - News) (OTCQB:SOLCF - News) (Frankfurt: 9SB) is pleased to announce that its portfolio company, Heavenly Rx. Ltd. ("Heavenly Rx"), has closed on its US$30.06 million investment in Blühen Botanicals LLC ("Blühen"), an industry-leading hemp and hemp-derived CBD biomass farming, processing, extraction and retail company headquartered in Knoxville, Tennessee. SOL Global had previously announced the assignment of its rights to acquire Blühen to Heavenly Rx on February 25, 2019.

  • SOL Global Adds California to Its MSO Portfolio with Proposed Acquisition of Premiere Cultivation, Processing, and Dispensary Companies
    CNW Group2 months ago

    SOL Global Adds California to Its MSO Portfolio with Proposed Acquisition of Premiere Cultivation, Processing, and Dispensary Companies

    TORONTO, May 16, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (CSE:SOL.CN - News) (OTCQB:SOLCF - News) (Frankfurt: 9SB) is pleased to announce that it has entered into letters of intent to acquire ECD, Inc., which operates as Northern Emeralds ("Northern Emeralds"), an industry leading cannabis cultivation, processing and distribution company headquartered in Humboldt County, California, as well as six (6) licensed dispensary companies in California that will subsequently operate under the nationally recognized "One Plant" brand. SOL Global intends to open One Plant-branded dispensaries throughout California (a total of 20 operating and licensed dispensary companies), Florida, and Michigan.

  • Market Exclusive3 months ago

    SOL Agrees to Buy Merida’s Michigan Cannabis Business

    SOL Global Investments (CSE: SOL) (OTCQB: SOLCF) (Frankfurt: 9SB) is acquiring MCP Wellness, a subsidiary of Merida Capital Partners. SOL signed a binding letter of intent with cannabis-focused private equity firm Merida to acquire its Michigan cannabis business for US$150 million. MCP Focuses on Michigan Cannabis Market MCP Wellness, a special-purpose vehicle created to invest […]The post SOL Agrees to Buy Merida's Michigan Cannabis Business appeared first on Market Exclusive.

  • SOL Global Signs Binding Agreement with Merida Capital Partners' Subsidiary to Acquire Michigan Fully Licensed Cannabis Business
    CNW Group3 months ago

    SOL Global Signs Binding Agreement with Merida Capital Partners' Subsidiary to Acquire Michigan Fully Licensed Cannabis Business

    TORONTO, April 24, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (CSE:SOL.CN - News) (OTCQB:SOLCF - News) (Frankfurt: 9SB), the owner of 3 Boys Farms, LLC ("3 Boys"), which holds one of Florida's original 14 operating and vertically integrated medical marijuana treatment center licenses, is pleased to announce that it has entered into a binding letter of intent ("LOI") with cannabis-focused private equity firm Merida Capital Partners ("Merida") dated April 23, 2019 to acquire Merida's Michigan subsidiary, MCP Wellness, Inc. ("MCP Wellness") for an aggregate purchase price of US$150 million (the "Acquisition"). MCP Wellness, a special-purpose vehicle (SPV) created to invest in Michigan cannabis operations, currently holds the rights to acquire two Michigan cultivation licenses, a processing license, and 3 fully licensed cannabis provisioning centers in Michigan with a fourth provisioning center scheduled to open in Ann Arbor in May.

  • SOL Global Announces 3 Boys Farms' Receipt of Approval to Dispense Cannabis Flower and Pre-Roll Products in Florida
    CNW Group3 months ago

    SOL Global Announces 3 Boys Farms' Receipt of Approval to Dispense Cannabis Flower and Pre-Roll Products in Florida

    TORONTO, April 22, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (CSE:SOL.CN - News) (OTCQB:SOLCF - News) (Frankfurt: 9SB) is pleased to announce that 3 Boys Farms, LLC ("3 Boys Farm"), which owns and operates one of the twenty-two (22) medical marijuana treatment center licenses in Florida, has received approval from the State of Florida's Department of Health, Office of Medical Marijuana Use ("OMMU") to begin dispensing its premium, organically cultivated cannabis flower and pre-rolled products at its new state-of-the-art extraction and processing facility in Indiantown, Florida. SOL Global completed its acquisition of 3 Boys Farms earlier this month through the closing of its purchase of CannCure Investments Inc.

  • SOL Global's CBD and Hemp Portfolio Company, Heavenly Rx, Closes Private Placement Financing of Over $12 Million
    CNW Group3 months ago

    SOL Global's CBD and Hemp Portfolio Company, Heavenly Rx, Closes Private Placement Financing of Over $12 Million

    TORONTO, April 18, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (CSE:SOL.CN - News) (OTCQB:SOLCF - News) (Frankfurt: 9SB) is pleased to announce that it has completed multiple tranches of a non-brokered private placement financing of common shares of its subsidiary, Heavenly Rx Ltd. ("Heavenly Rx"), for aggregate gross proceeds of $12,586,250 (the "Offering"). An aggregate of 125,862,500 common shares in the capital of Heavenly Rx ("Heavenly Shares") were issued and sold at a price of $0.10 per Heavenly Share. As a result of this financing, SOL Global now holds 34.40% of the issued and outstanding Heavenly Shares with the subscribers from the Offering collectively holding the remaining 65.60%.

  • GlobeNewswire3 months ago

    Cannabrand Awareness - Cannabis Companies Shift Focus to Branding and Marketing Strategies

    Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at how, as the cannabis sector matures there is a parallel shift towards brand recognition through acquisitions, marketing partnerships with other well-known brands, or celebrities endorsements to gain market dominance. Cannabis One Holdings Inc. (CSE:CBIS), an emerging, premier "House of Brands" in North America, is also focusing on brand partnerships, having  just announced that it has executed a definitive asset purchase agreement to acquire certain assets of Washington-based Honu Enterprises Inc., an award-winning cannabis-infused products brand.  The wide variety of Honu-branded products have been consistent favourites among consumers and are top performers in cannabis industry competitions – Honu was declared Best Edibles Company at the 2016 Dope Industry Awards and won the category of Best Sweet Edible in Washington State for its "Coconut Snowball" edible at the 2016 Dope Cup.

  • SOL Global Completes Acquisition of 3 Boys Farms through the Purchase of CannCure Investments Inc.
    CNW Group3 months ago

    SOL Global Completes Acquisition of 3 Boys Farms through the Purchase of CannCure Investments Inc.

    Pursuant to the terms of an amended and restated share purchase agreement (the "Amended Purchase Agreement") between the Company, CannCure and the shareholders of CannCure (the "Sellers"), SOL Global acquired all of the issued and outstanding common shares of CannCure for a revised purchase price of US$41,207,519, which was partially satisfied by the issuance of 7,317,500 common shares of SOL Global ("Consideration Shares") at a negotiated price of CAD $4.00 per share to the Sellers on a pro-rata basis.

  • GlobeNewswire3 months ago

    Exactus Applauds Executive Chairman, Jonathan Gilbert on Launch of Impact Biosciences Corp.

    Exactus Inc. (EXDI), a healthcare company pursuing opportunities in Hemp derived Cannabidiol (CBD) products, applauds its Executive Chairman of the Board, Jonathan Gilbert, on the launch of Impact Biosciences Corp. Jonathan Gilbert, cannabis industry veteran, and founder and former CEO of SOL Global Investments Corp. (CSE:SOL) (9SB.F) (SOLCF), whose wholly owned subsidiary, Scythian Biosciences Inc. (“SBI”), is seeking to list SBI as a new public company on the Canadian Stock Exchange (“CSE”) following a successful capital raise and spinout.

  • SOL Global to Spin Off Cannabinoid Drug Therapy Research and Development Subsidiary
    CNW Group3 months ago

    SOL Global to Spin Off Cannabinoid Drug Therapy Research and Development Subsidiary

    TORONTO, April 5, 2019 /CNW/ - SOL Global Investments Corp. ("SOL" or the "Company") (CSE:SOL.CN - News) (Frankfurt:9SB.F - News) (OTCQB:SOLCF - News)  is pleased to announce that it intends to spin off its wholly-owned subsidiary, Scythian Biosciences Inc. ("SBI"), into an independent, publicly-traded company (the "Spin-off"). In connection with the Spin-off, SBI will be renamed "Impact Biosciences Corp" ("Impact") and will continue to pursue a drug development in the United States for the treatment of concussions and traumatic brain injury with its proprietary Cannabinoid combination drug candidate, which is being developed under contract with the University of Miami. Impact's mission is to become the first accepted drug regimen for concussive treatment.